Skip to main content

Animations

MJFF Publications

7421 - 7430 of 9033 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2024
  • 2024
  • 2018
  • 2021
  • 2016
  • 2021
  • 2024
  • 2019
  • Summary Details
    OPEN
    Title: A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.40202
    Citation Count: 270
  • Summary Details
    OPEN
    Title: Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00036
    Citation Count: 101
  • Summary Details
    OPEN
    Title: LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-024-00403-2
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    Journal Name: eClinicalMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004
    Citation Count: 148
  • Compensatory Mechanisms Nine Years Before Parkinson's Disease Conversion in a LRRK2 R1441H Family
    2021
    Summary Details
    RESTRICTED
    Title: Compensatory Mechanisms Nine Years Before Parkinson's Disease Conversion in a LRRK2 R1441H Family
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28833
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Olfactory impairment predicts cognitive decline in early Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.013
    Citation Count: 124
  • Summary Details
    OPEN
    Title: Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jev2.12182
    Citation Count: 344
  • Summary Details
    OPEN
    Title: Rapid 2D 23Na MRI of the calf using a denoising convolutional neural network
    Journal Name: Magnetic Resonance Imaging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.mri.2024.04.027
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Spring is in the air: seasonal profiles indicate vernal change of miRNA activity
    Journal Name: RNA Biology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15476286.2019.1612217
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.